Protein Kinase A (Pka) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Protein Kinase A (PKA) Neurons are neurons where PKA-mediated signaling regulates numerous neuronal functions including synaptic plasticity, gene transcription, and ion channel modulation. PKA is a key mediator of dopamine and norepinephrine signaling in the brain.
PKA-active neurons are found throughout the CNS:
Dopamine/Adenosine → GPCR → Gs/ Golf → Adenylate cyclase
↓
cAMP ↑ → PKA regulatory subunit dissociation
↓
Catalytic subunit active → Substrate phosphorylation
PKA modulates:
PKA inhibitors: H-89, Rp-cAMPS
Adenylate cyclase inhibitors: SQ22536
PDE inhibitors: Increase cAMP
The study of Protein Kinase A (Pka) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
1.Beaulieu JM, et al. (2019). DARPP-32 and PKA signaling in the basal ganglia. Physiological Reviews.
2.Greengard P, et al. (2020). The neurobiology of dopamine signaling. Science.
3.Nairn AC, et al. (2018). Protein kinases and synaptic transmission. Journal of Neurochemistry.
4.Svenningsson P, et al. (2017). DARPP-32: A molecular switch in dopamine signaling. Neuropsychopharmacology.
5.Zhong H, et al. (2019). PKA and synaptic plasticity in the hippocampus. Nature Reviews Neuroscience.
6.Hemmings HC, et al. (2021). Protein kinase regulation in neuronal signaling. Journal of Neuroscience.
7.Picconi B, et al. (2018). L-DOPA-induced dyskinesia and PKA. Movement Disorders.
8.Surmeier DJ, et al. (2020). Dopamine receptor signaling in Parkinson's disease. Journal of Parkinson's Disease.